Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06149429 · ClinicalTrials.gov registry record · NA

Virtual Reality at End-of-life

A NA study of Depression and Pain, sponsored by State University of New York at Buffalo.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT06149429: Completed NA study of Depression and Pain, sponsored by State University of New York at Buffalo.

NCT06149429 is a NA study of Depression and Pain that has completed, run by State University of New York at Buffalo. The registered enrollment target is 9 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06149429, a NA study of Depression and Pain, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to determine the effect that repeated, personalized virtual reality experiences have on symptom severity, comparing self-reported symptom severity both pre and post each session, and overtime across sessions. Researchers will also determine if this intervention results in a high rating of presence in VR, and if presence is related to the magnitude of the change in symptoms.

Primary Outcome

End-of-life symptom assessment

Conditions Studied

Depression Pain Anxiety Fatigue Dyspnea Well-Being, Psychological Nausea End of Life Appetite Loss

Interventions

  • BEHAVIORAL Personalized virtual reality experience

Study Locations (1)

New York

  • Hospice and Palliative Care Buffalo - Cheektowaga

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2023-10-23
Est. Completion 2024-07-15
Phase NA
State University of New York at Buffalo

243 total trials

What the finished NCT06149429 record still lists

NCT06149429 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower).

The record links to 9 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Personalized virtual reality experience is the first listed.

NCT06149429 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06149429 about?

NCT06149429 is a clinical study titled "Virtual Reality at End-of-life". The purpose of this research is to determine the effect that repeated, personalized virtual reality experiences have on symptom severity, comparing self-reported symptom severity both pre and post each session, and overtime across sessions. Researchers will also determine if this intervention result...

What is the current status of trial NCT06149429?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2023-10-23. Estimated completion is 2024-07-15.

What conditions does trial NCT06149429 study?

This clinical trial studies the following conditions: Depression, Pain, Anxiety, Fatigue, Dyspnea.

What interventions are being tested in trial NCT06149429?

The interventions under investigation include: Personalized virtual reality experience (BEHAVIORAL).

Who is sponsoring clinical trial NCT06149429?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06149429 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06149429's enrollment target sits among peer trials

9 664th of 679 higher than 14 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Related registry views

Source: ClinicalTrials.gov NCT06149429, the US trial registry maintained by the National Library of Medicine. NCT06149429 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.